Clinical Trials · NCT04727671

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.

CompletedPhase 4Gonadorelin (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Damascus University
Enrollment
50
Start date
Dec 2019
Locations
1 site, Syria
Primary endpoint
Follicular fluid Placental Growth Factor (PlGF) Concentrations:
View Gonadorelin compound reference